Literature DB >> 24783018

Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism?

Torquil Watt1, Laszlo Hegedüs2, Jakob Bue Bjorner3, Mogens Groenvold4, Steen Joop Bonnema2, Ase Krogh Rasmussen5, Ulla Feldt-Rasmussen5.   

Abstract

PURPOSE: To evaluate the relationship between thyroid variables and health-related quality of life (QoL) in patients with autoimmune hypothyroidism, using the thyroid-specific QoL questionnaire ThyPRO.
METHODS: In a cross-sectional study, responses to the ThyPRO from 199 outpatients with autoimmune hypothyroidism were analyzed in relation to thyroid volume, thyroid function and markers of thyroid autoimmunity. Based on a classical QoL framework, we hypothesized that physiological dysfunction caused specific physical and psychological symptoms, which affected functioning and well-being, and consequently participation in life and QoL. These hypotheses were tested through multiple regression and multivariate path analysis models.
RESULTS: None of the thyroid function tests were associated with QoL scores. However, in the pairwise regression, the thyroid peroxidase antibody (TPOAb) level was associated with several QoL outcomes: Goitre Symptoms (p = 0.024), Depressivity (p = 0.004), Anxiety (p = 0.004), Emotional Susceptibility (p = 0.005) and Impaired Social Life (p = 0.047). In the multivariate model, the TPOAb level was related to Goitre Symptoms (r = 0.17, p = 0.019), Depressivity (r = 0.24, p = 0.001), and Anxiety (r = 0.23, p = 0.002), but no longer to Emotional Susceptibility or Impaired Social Life, indicating that the effect on these were mediated through an effect on the symptom scales (i.e. Goitre Symptoms, Depressivity and Anxiety).
CONCLUSION: Health-related QoL, evaluated with state-of-the-art QoL methodology, was related to TPOAb level but not to thyroid function. This raises the hypothesis that autoimmunity, independent of thyroid function, impacts on QoL in patients with autoimmune hypothyroidism, especially in terms of psychological symptoms. Longitudinal studies, in initially untreated patients, are needed to test this hypothesis.

Entities:  

Keywords:  Autoimmune hypothyroidism; Autoimmunity; Clinical variables; Quality of life

Year:  2012        PMID: 24783018      PMCID: PMC3821477          DOI: 10.1159/000342623

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  36 in total

Review 1.  Thyroid ultrasound.

Authors:  L Hegedüs
Journal:  Endocrinol Metab Clin North Am       Date:  2001-06       Impact factor: 4.741

Review 2.  Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.

Authors:  Laszlo Hegedüs; Terry J Smith; Raymond S Douglas; Claus H Nielsen
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

3.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.

Authors:  M P Mourits; M F Prummel; W M Wiersinga; L Koornneef
Journal:  Clin Endocrinol (Oxf)       Date:  1997-07       Impact factor: 3.478

4.  Computer-based screening system for patients at risk of hypothyroidism.

Authors:  D J Barker; J M Bishop
Journal:  Lancet       Date:  1969-10-18       Impact factor: 79.321

5.  Skeletal muscle microvascular alterations in euthyroid and hypothyroid patients with autoimmune thyroid disease.

Authors:  A Márquez; H J Finol; M C De Blanco; H Adjounian; M Pulido-Méndez
Journal:  J Submicrosc Cytol Pathol       Date:  2001-10

6.  Application of structural equation modeling to health outcomes research.

Authors:  Ron D Hays; Dennis Revicki; Karin S Coyne
Journal:  Eval Health Prof       Date:  2005-09       Impact factor: 2.651

Review 7.  Hashimoto's encephalopathy.

Authors:  Nicoline Schiess; Carlos A Pardo
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 8.  The thyroid-brain interaction in thyroid disorders and mood disorders.

Authors:  M Bauer; T Goetz; T Glenn; P C Whybrow
Journal:  J Neuroendocrinol       Date:  2008-07-30       Impact factor: 3.627

Review 9.  Quality of life in patients with benign thyroid disorders. A review.

Authors:  Torquil Watt; Mogens Groenvold; Ase Krogh Rasmussen; Steen Joop Bonnema; Laszlo Hegedüs; Jakob Bue Bjorner; Ulla Feldt-Rasmussen
Journal:  Eur J Endocrinol       Date:  2006-04       Impact factor: 6.664

10.  Which domains of thyroid-related quality of life are most relevant? Patients and clinicians provide complementary perspectives.

Authors:  Torquil Watt; Laszlo Hegedüs; Ase Krogh Rasmussen; Mogens Groenvold; Steen Joop Bonnema; Jakob Bue Bjorner; Ulla Feldt-Rasmussen
Journal:  Thyroid       Date:  2007-07       Impact factor: 6.568

View more
  22 in total

1.  Depressive symptoms, thyroid hormone and autoimmunity in a population-based cohort from Sardinia.

Authors:  Alessandro P Delitala; Antonio Terracciano; Edoardo Fiorillo; Valeria Orrù; David Schlessinger; Francesco Cucca
Journal:  J Affect Disord       Date:  2015-11-26       Impact factor: 4.839

Review 2.  Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.

Authors:  Wilmar M Wiersinga
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

Review 3.  Brain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It.

Authors:  Mary H Samuels; Lori J Bernstein
Journal:  Thyroid       Date:  2022-05-05       Impact factor: 6.506

4.  Improvement of quality of life in patients with benign goiter after surgical treatment.

Authors:  Branka R Bukvic; Vladan R Zivaljevic; Sandra B Sipetic; Aleksandar D Diklic; Katarina M Tausanovic; Ivan R Paunovic
Journal:  Langenbecks Arch Surg       Date:  2014-07-08       Impact factor: 3.445

5.  Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO.

Authors:  Torquil Watt; Giuseppe Barbesino; Jakob Bue Bjorner; Steen Joop Bonnema; Branka Bukvic; Russell Drummond; Mogens Groenvold; Laszlo Hegedüs; Valeska Kantzer; Kathryn E Lasch; Claudio Marcocci; Anjali Mishra; Romana Netea-Maier; Merel Ekker; Ivan Paunovic; Terence J Quinn; Åse Krogh Rasmussen; Audrey Russell; Mayilvaganan Sabaretnam; Johannes Smit; Ove Törring; Vladan Zivaljevic; Ulla Feldt-Rasmussen
Journal:  Qual Life Res       Date:  2014-09-07       Impact factor: 4.147

6.  THE ROMANIAN VERSION OF THE THYROID-RELATED PATIENT-REPORTED OUTCOMES THYPRO AND THYPRO-39. TRANSLATION AND ASSESSMENT OF RELIABILITY AND CROSS-CULTURAL VALIDITY.

Authors:  A E Zahan; T Watt; I Pascanu; A K Rasmussen; L Hegedüs; S J Bonnema; U Feldt-Rasmussen; J B Bjorner; V Nadasan; A Boila; I Merlan; A Borda
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Apr-Jun       Impact factor: 0.877

7.  A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Hashimoto's Thyroiditis.

Authors:  Kristian Hillert Winther; Enrico Papini; Roberto Attanasio; Roberto Negro; Laszlo Hegedüs
Journal:  Eur Thyroid J       Date:  2020-01-14

Review 8.  Persisting symptoms in patients with Hashimoto's disease despite normal thyroid hormone levels: Does thyroid autoimmunity play a role? A systematic review.

Authors:  Karelina L Groenewegen; Christiaan F Mooij; A S Paul van Trotsenburg
Journal:  J Transl Autoimmun       Date:  2021-04-15

Review 9.  Primary hypothyroidism and quality of life.

Authors:  Laszlo Hegedüs; Antonio C Bianco; Jacqueline Jonklaas; Simon H Pearce; Anthony P Weetman; Petros Perros
Journal:  Nat Rev Endocrinol       Date:  2022-01-18       Impact factor: 47.564

10.  Predictors of Improvement in Quality of Life When Treating Hypothyroidism.

Authors:  Bjarke Borregaard Medici; Jeppe Lerche la Cour; Filip Krag Knop; Martin Krakauer; Luba Freja Michaelsson; Jens Faber; Torquil Watt; Birte Nygaard
Journal:  J Thyroid Res       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.